Oxidant, antioxidant status and metabolic data in patients with beta-thalassemia. - Wikidata - awgldk - TriplyDB

Oxidant, antioxidant status and metabolic data in patients with beta-thalassemia.

Oxidant, antioxidant status and metabolic data in patients with beta-thalassemia.

http://www.wikidata.org/entity/Q30884732

about

Oxidative stress and age-related changes in T cells: is thalassemia a model of accelerated immune system aging?Renal complications of beta-thalassemia major in children Up-regulation of heme oxygenase-1 in rat spleen after aniline exposure Vascular endothelial dysfunction in β-thalassemia occurs despite increased eNOS expression and preserved vascular smooth muscle cell reactivity to NO Is supplementation efficacious in maintaining adequate plasma levels of vitamin a and e for thalassemic patients undergoing hematopoietic stem cell transplantation? A cross-sectional study.Respiratory Burst Enzymes, Pro-Oxidants and Antioxidants Status in Bangladeshi Population with β-Thalassemia Major.GFR in Patients with β-Thalassemia Major.Increased Heme Levels in the Heart Lead to Exacerbated Ischemic Injury.Effects of Vitamin E and Zinc Supplementation on Antioxidants in Beta thalassemia major Patients Total Antioxidant Status in Patients with Major β-Thalassemia.Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease.Detection of glycemic abnormalities in adolescents with beta thalassemia using continuous glucose monitoring and oral glucose tolerance in adolescents and young adults with β-thalassemia major: Pilot study.Retinal nerve fiber layer thickness and retinal vessel calibers in children with thalassemia minor.The Benefits of vitamin E on liver function and the hemopoietic System in thalassemia Patients.Nutritional biomarkers in children and adolescents with Beta-thalassemia-major: An Egyptian center experience Correlation of oxidative stress with serum trace element levels and antioxidant enzyme status in Beta thalassemia major patients: a review of the literature.Renal aspects of thalassaemia a changing paradigm.Selenoproteins are involved in antioxidant defense systems in thalassemia.Benefits of Curcumin Supplementation on Antioxidant Status in β-Thalassemia Major Patients: A Double-Blind Randomized Controlled Clinical Trial.Glutathione S-transferase gene polymorphism: Relation to cardiac iron overload in Egyptian patients with Beta Thalassemia Major.Role of vitamin C as an adjuvant therapy to different iron chelators in young β-thalassemia major patients: efficacy and safety in relation to tissue iron overload.Exacerbation of insulin resistance and hepatic steatosis deriving from zinc deficiency in patients with HCV-related chronic liver disease.Early Predictors of Renal Dysfunction in Egyptian Patients with β-Thalassemia Major and Intermedia Growth Parameters and Vitamin D status in Children with Thalassemia Major in Upper Egypt Zinc and copper status in children with Beta-thalassemia major.Erythrocytes anion transport and oxidative change in beta-thalassaemias.Oxidative status and plasma lipid profile in β-thalassemia patients.Heme-oxygenase-mediated iron accumulation in the liver.Ischemia-modified albumin as a marker of vascular dysfunction and subclinical atherosclerosis in β-thalassemia major.Serum Paraoxonase Activity and Malondialdehyde Serum Concentrations Remain Unaffected in Response to Hydroxyurea Therapy in β-Thalassemia Patients.Quantitative determination of ortho- and meta-tyrosine as biomarkers of protein oxidative damage in beta-thalassemia.The Impact of Transfusion and Chelation on Oxidative Stress in Immigrant Syrian Children with β-Thalassemia.Effect of oxidative stress on membrane proteins in thalassemia and iron deficiency anemia.Cytokine-induced apoptosis of beta-thalassemia/hemoglobin E erythroid progenitor cells via nitric oxide-mediated process in vitro.Iron-chelating and free-radical scavenging activities of microwave-processed green tea in iron overload.Effect of zinc supplementation on serum antibody titers to heat shock protein 27 in patients with thalassemia major.Urinary early kidney injury molecules in children with beta-thalassemia major Glomerular Hyperfiltration and Proteinuria in Transfusion-Independent Patients with β-Thalassemia Intermedia Low IL-2 Expressing T Cells in Thalassemia Major Patients: Is It Immune Aging

P2860

Q26752041-F42D3C43-495C-4E7A-835D-DBDDF8D3E378 Q26825207-BBE84853-EC67-4B4B-AABD-7C7520FB4C4D Q33639018-8598DB8C-7315-490D-A679-44EEB2F350ED Q34313817-B7E4DB32-0BB1-4073-99C5-AE2D8BDD0767 Q35177304-601512B6-C2E9-4D90-B60A-18039DBC4634 Q35809497-9EDC6EEB-4037-4995-A113-1AE7E87C0B4C Q35922753-744F3AAE-F335-4743-AAEE-6BF8AA3FEB34 Q36141698-4E3ECBC4-FAC9-446D-85F6-9F9AA10A1824 Q36244677-CD734F7C-731F-4C12-B50B-CAC6F91E7FDD Q36244798-4640AD0D-FC7D-4BB7-9D64-E00DF93576AF Q36343351-6EA88D45-EF40-4392-AF5F-6E6E07585518 Q37016018-63F836F6-662D-41F0-BA40-497B36F1E429 Q37151789-69116E25-AF30-4707-ACC6-A4AE7CAA5351 Q37560067-99292592-6161-4425-9AF6-1FF59557E117 Q37725498-5ECD4E4E-CCBD-4E78-82D7-FA3395BD798C Q38014440-E26DC320-5E2C-4F53-8AD8-EE229AA8B168 Q38017754-1AA4571C-2EA3-4693-A954-A822CE691F72 Q38702938-DE1B2645-0E08-4EB4-8FAB-8E04818AE8CB Q39150076-550A218C-3CEC-48D1-84F4-61240AF8D663 Q39260470-428B51D7-94F8-4FAC-83E8-CBA5C5D05F7A Q40896307-15884108-2E6C-4186-99C0-D3F1C510AD4A Q41654021-7887CF35-9801-4A35-BBD2-FEDF96EE07E7 Q41817772-5D042DB5-A9D9-47CC-A581-9195B1E8C423 Q41919787-F2159E3D-1FA4-41A2-80A9-0AF132868681 Q42326172-7894D57D-F4AB-49A5-B3EF-628DA64D375A Q43070068-A4D65FCE-C2C9-47D3-ADE5-B44C7BA31166 Q44478196-1E450EF8-E85C-4BCB-890E-0B074E3B35A6 Q45076007-9BF6C33A-57FC-4DFC-9CCD-851C9E4A51B9 Q46460675-72DB891A-B1C0-4064-9332-0B86479D1DDE Q46633489-3DED173C-A270-4E63-97DC-2DF46C74025E Q46959226-1FC78936-3009-4ED0-8DC0-0D502744021C Q48120038-156E4A81-A9E8-4BA5-A713-7916F38F294C Q50436027-58C84AE0-1EF4-4E7B-8DEE-32473F535134 Q50525886-321280BE-B952-4A5F-AD53-A429D4C21CF4 Q50725581-2F7954D3-F72C-4BE3-A0F2-57F8504A9E90 Q50985408-3431FA07-3ADE-43E7-8E99-4CCED59FEB9A Q57593508-3DB2C1B6-0317-488A-B2CF-94F9B401DAC7 Q57998227-952CCDC2-4116-45D2-A4C1-049FFA4FEA14 Q58125047-784750B0-8CE2-4754-A140-83A22D2AA0E9

P2860

Oxidant, antioxidant status and metabolic data in patients with beta-thalassemia.

http://www.wikidata.org/entity/Q30884732

description

2003 nî lūn-bûn

@nan

2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Oxidant, antioxidant status and metabolic data in patients with beta-thalassemia.

@ast

Oxidant, antioxidant status and metabolic data in patients with beta-thalassemia.

@en

type

label

Oxidant, antioxidant status and metabolic data in patients with beta-thalassemia.

@ast

Oxidant, antioxidant status and metabolic data in patients with beta-thalassemia.

@en

prefLabel

Oxidant, antioxidant status and metabolic data in patients with beta-thalassemia.

@ast

Oxidant, antioxidant status and metabolic data in patients with beta-thalassemia.

@en

P1433

Q30884732-7516BEBE-5342-4FDF-9F71-26709D2CA814

P1476

Q30884732-919130B7-1B20-4448-9615-7E3435AAE786

P2093

Q30884732-01FA92FF-B149-4C53-AEEE-B6F93443DF84

Q30884732-18AD6649-4EB5-4512-9293-638590963643

Q30884732-3181A169-9D69-45EB-8806-530229BC7EEA

Q30884732-AAD86AB3-271A-4AFD-809B-EB196FC2A58C

Q30884732-C3E71D89-BD3A-4E02-843E-452B242A8EFD

Q30884732-D86B7F20-9447-45A0-9BE8-A581F3ED5909

Q30884732-E2D1DE71-DB59-47FB-8103-F924B393EB61

Q30884732-E4FD20A2-0848-4DA2-8019-686C90B949C9

Q30884732-F1B1FD71-A1D1-4887-8EB1-1F886FE7E8D9

P304

Q30884732-84CE6966-27E8-4D2E-B6C9-0FA77AAC1C1F

P31

Q30884732-244DFB52-90BD-465B-B819-2D4EF347A719

P356

Q30884732-6B84965D-6A90-4E46-97DE-0AD33F0526A6

P433

Q30884732-44E35FA1-4FB6-49B4-BA8E-2960CCF73DE5

P478

Q30884732-1F9AEA5B-ED8F-4EF0-A9BB-7834A598F846

P577

Q30884732-25DD0EA5-F70D-4509-9559-B6C544C31CC0

P698

Q30884732-1B56D934-2B0B-4818-9683-A841D9A8D5E0

P356

J.CCCN.2003.07.010

P1433

Clinica Chimica Acta

P1476

Oxidant, antioxidant status and metabolic data in patients with beta-thalassemia.

@en

P2093

Abdelhédi Miled

http://www.w3.org/2001/XMLSchema#string

Amel Haj Khelil

http://www.w3.org/2001/XMLSchema#string

Asma Kassab-Chekir

http://www.w3.org/2001/XMLSchema#string

Fathi Amri

http://www.w3.org/2001/XMLSchema#string

Habib Selmi

http://www.w3.org/2001/XMLSchema#string

Mohamed Bejaoui

http://www.w3.org/2001/XMLSchema#string

Moncef Feki

http://www.w3.org/2001/XMLSchema#string

Sandrine Laradi

http://www.w3.org/2001/XMLSchema#string

Selima Ferchichi

http://www.w3.org/2001/XMLSchema#string

P304

79-86

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CCCN.2003.07.010

http://www.w3.org/2001/XMLSchema#string

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

338

http://www.w3.org/2001/XMLSchema#string

P577

2003-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14637270

http://www.w3.org/2001/XMLSchema#string